慢性阻塞性肺疾病
Chronic Obstructive Pulmonary Disease.
作者信息
O'Reilly Sean
机构信息
Pulmonary, Critical Care, and Sleep Medicine, Sentara Martha Jefferson Medical Group, Sentara Martha Jefferson Hospital, Charlottesville, Virginia.
出版信息
Am J Lifestyle Med. 2016 Jul 7;11(4):296-302. doi: 10.1177/1559827616656593. eCollection 2017 Jul-Aug.
Abstract
COPD is a common, preventable, and treatable disease characterized by persistent airflow obstruction associated with enhanced inflammation in the airways and the lung in response to noxious particles or gases. Clinical history and pulmonary function testing are necessary for accurate diagnosis. While exposure to tobacco smoke remains a common cause, other etiologies and underlying genetic predisposition play significant roles. Treatment options are numerous and should be individualized based on symptoms and exacerbation frequency.
摘要
慢性阻塞性肺疾病（COPD）是一种常见、可预防且可治疗的疾病，其特征为持续气流受限，伴有气道和肺部对有害颗粒或气体的炎症反应增强。准确诊断需要临床病史和肺功能测试。虽然接触烟草烟雾仍是常见病因，但其他病因和潜在的遗传易感性也起着重要作用。治疗选择众多，应根据症状和急性加重频率进行个体化治疗。
相似文献
1
Chronic Obstructive Pulmonary Disease.
Am J Lifestyle Med. 2016 Jul 7;11(4):296-302. doi: 10.1177/1559827616656593. eCollection 2017 Jul-Aug.
2
COPD: definition and phenotypes.
Clin Chest Med. 2014 Mar;35(1):1-6. doi: 10.1016/j.ccm.2013.10.010. Epub 2013 Dec 12.
3
Chronic obstructive pulmonary disease in a new concept.
Rom J Morphol Embryol. 2007;48(3):207-14.
4
Regenerative and translational medicine in COPD: hype and hope.
Eur Respir Rev. 2023 Jul 26;32(169). doi: 10.1183/16000617.0223-2022. Print 2023 Sep 30.
5
[Chronic obstructive pulmonary disease (COPD) as a systemic disease].
Dtsch Med Wochenschr. 2009 Jun;134(23):1231-5. doi: 10.1055/s-0029-1222594. Epub 2009 May 14.
6
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
7
Genetic polymorphisms and their involvement in the regulation of the inflammatory response in asthma and COPD.
Adv Clin Exp Med. 2018 Jan;27(1):125-133. doi: 10.17219/acem/65691.
9
New pharmacological treatments for patients with chronic obstructive pulmonary disease (COPD).
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Mar;155(1):43-50. doi: 10.5507/bp.2011.017.
10
The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease.
Am J Med Sci. 2005 Apr;329(4):181-9. doi: 10.1097/00000441-200504000-00004.
引用本文的文献
1
Smoking and asthma mediate the protective effect of educational attainment on chronic obstructive pulmonary disease risk: a mediation Mendelian randomization analysis.
BMC Pulm Med. 2025 Apr 30;25(1):209. doi: 10.1186/s12890-025-03658-1.
2
Decreased fucosylation impacts epithelial integrity and increases risk for COPD.
bioRxiv. 2023 Nov 2:2023.10.31.564805. doi: 10.1101/2023.10.31.564805.
3
Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
Can Respir J. 2023 Apr 26;2023:8678702. doi: 10.1155/2023/8678702. eCollection 2023.
4
Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.
J Drug Deliv Sci Technol. 2022 Aug;74:103541. doi: 10.1016/j.jddst.2022.103541. Epub 2022 Jun 23.
5
Reducing Anxiety to Increase Exercise in Individuals With Decreased Lung Capacity.
Am J Lifestyle Med. 2017 Apr 12;11(4):307-309. doi: 10.1177/1559827617703058. eCollection 2017 Jul-Aug.
6
Physical Inactivity, Self-Management, and Living Well With COPD.
Am J Lifestyle Med. 2017 Apr 4;11(4):303-306. doi: 10.1177/1559827617700596. eCollection 2017 Jul-Aug.
本文引用的文献
1
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Lancet Respir Med. 2014 Mar;2(3):187-94. doi: 10.1016/S2213-2600(13)70286-8. Epub 2014 Jan 30.
2
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2013 Nov 4(11):CD002309. doi: 10.1002/14651858.CD002309.pub4.
3
Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome.
J Clin Sleep Med. 2013 Aug 15;9(8):767-72. doi: 10.5664/jcsm.2916.
4
Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment?
Chest. 2013 Nov;144(5):1571-1577. doi: 10.1378/chest.13-0518.
5
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
JAMA. 2013 Jun 5;309(21):2223-31. doi: 10.1001/jama.2013.5023.
6
Daily step count predicts acute exacerbations in a US cohort with COPD.
PLoS One. 2013 Apr 4;8(4):e60400. doi: 10.1371/journal.pone.0060400. Print 2013.
7
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257.
8
Nutritional supplementation for stable chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD000998. doi: 10.1002/14651858.CD000998.pub3.
9
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2012 Aug 15(8):CD001287. doi: 10.1002/14651858.CD001287.pub4.
10
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD003573. doi: 10.1002/14651858.CD003573.pub2.
Zotero 插件